Deck 16: Anticoagulant, Antiplatelet, and Fibrinolytic Drugs

Full screen (f)
exit full mode
Question
Which anticoagulant consists of a synthetic antithrombin III-binding pentasaccharide?

A) fondaparinux
B) bivalirudin
C) warfarin
D) heparin
E) enoxaparin
Use Space or
up arrow
down arrow
to flip the card.
Question
A patient receives a cyclic peptide derived from rattlesnake venom. Which step leading to platelet aggregation is inhibited by this agent?

A) glycoprotein IIb/IIIa expression
B) ADP binding
C) fibrinogen binding
D) cyclic AMP formation
E) 5-hydroxytryptamine synthesis
Question
Which coagulation factor is inactivated following administration of lepirudin?

A) tissue thromboplastin
B) fibrinogen
C) prothrombin
D) active factor X
E) thrombin
Unlock Deck
Sign up to unlock the cards in this deck!
Unlock Deck
Unlock Deck
1/3
auto play flashcards
Play
simple tutorial
Full screen (f)
exit full mode
Deck 16: Anticoagulant, Antiplatelet, and Fibrinolytic Drugs
Which anticoagulant consists of a synthetic antithrombin III-binding pentasaccharide?

A) fondaparinux
B) bivalirudin
C) warfarin
D) heparin
E) enoxaparin
fondaparinux
A patient receives a cyclic peptide derived from rattlesnake venom. Which step leading to platelet aggregation is inhibited by this agent?

A) glycoprotein IIb/IIIa expression
B) ADP binding
C) fibrinogen binding
D) cyclic AMP formation
E) 5-hydroxytryptamine synthesis
fibrinogen binding
Which coagulation factor is inactivated following administration of lepirudin?

A) tissue thromboplastin
B) fibrinogen
C) prothrombin
D) active factor X
E) thrombin
active factor X
locked card icon
Unlock Deck
Unlock for access to all 3 flashcards in this deck.